SKHY: Great Print, Broken Tape — WATCH Until the Post-Earnings Gap Proves It Can Hold
Published · entry price $162.16 · machine-generated by the QuantLogix Thesis Engine and graded publicly at T+7/30/90 days · SKHY charts & signals →
SK hynix's Q3 beat (revenue +32% QoQ, 84% EBITDA margin, LTAs covering half of 2027/28 capacity) and Street targets of $235-$250 argue for upside, but the stock sits 18% below its September high after a 28% drawdown and a 13% one-day bounce. The platform engine is Neutral (53/100, 39% win probability), no qualifying cohort covers the name, and our scenario EV of $163 is only +0.7% vs spot. We publish WATCH: a close above $190 confirms the bounce, and a close below $135 breaks it.
Thesis
- SKHY holds above $135, below the ~$143 Oct 26 close that Cantor's target math implies, through the T+30 window; a close below $135 invalidates the post-earnings-reset thesis. — triggered 10/29/2026
- SKHY closes above $190, roughly the level of five sessions ago, within 30 trading days, confirming the earnings-driven recovery and turning the call constructive.
- SKHY closes above the $235 Needham target within 30 trading days; we regard this as a low-probability (<10%) outcome.
- SKHY revisits and closes below $145 within 30 trading days, meaning the Oct 28 gap fully fades; we regard this as a roughly 35% outcome.
Evidence Graph4 of 4 claims linked · 4 preserved sources
This graph uses only evidence frozen into the thesis at publication on 10/29/2026. “Retrieved source passage” is the preserved grounding excerpt the engine saw; “published note passage” is thesis context, not a source quote. Missing edges and dates remain visible.
SKHY holds above $135, below the ~$143 Oct 26 close that Cantor's target math implies, through the T+30 window; a close below $135 invalidates the post-earnings-reset thesis.
Cantor's $250 target is 75% above Monday's close, which implies a ~$143 low, and the stock was 28% off its September high on CXMT and AI-capex worries.
Retrieved source passage
Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far TIKR.com Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far Gian Estrada • 5 minute read Reviewed by: David Hanson Last updated Oct 27, 2026 cyano66 from Getty Images and Petrovich9 from Getty Images Signature via Canva Key Takeaways - Cantor Fitzgerald cut its SK hynix price target to $250 from $300 on Oct. 26 and kept its Overweight rating. The new target is 75% above Monday’s close. - SK hynix is 28% below its September high after China’s CXMT claimed a denser DRAM design and worries about AI spending came back. - The $250 target works out to about 7.4x next-twelve-months earnings, against about
Needham cites Q3 DRAM/NAND beats and notes the stock rose 13.3% on the print, supporting a reset low at the Oct 26 close.
Retrieved source passage
Needham raises SK Hynix stock price target to $235 on supply outlook By Investing.com Needham raises SK Hynix stock price target to $235 on supply outlook Analyst Ratings Published Oct 28, 2026, 07:14 AM In this article: SKHY+13.30% Investing.com - Needham raised its price target on SK Hynix Inc. (NASDAQ:SKHY) to $235 from $220 while maintaining a Buy rating on the stock. The firm cited the company’s third-quarter results, which exceeded expectations for both DRAM and NAND products. The memory chip maker’s financial strength is evident in its impressive 76% gross profit margin and remarkably low P/E ratio of 5.6, suggesting strong profitability despite recent market volatility. Needham sai
SKHY closes above $190, roughly the level of five sessions ago, within 30 trading days, confirming the earnings-driven recovery and turning the call constructive.
Record 84% EBITDA margin, a 6% revenue beat and LTAs covering half of 2027/28 capacity argue for earnings durability.
Retrieved source passage
SK hynix Q3: The Memory Cycle May Have Changed. Has The Market Noticed? (NASDAQ:SKHY) Seeking Alpha SK hynix Q3: The Memory Cycle May Have Changed. Has The Market Noticed? Oct 28, 2026, 8:15 AM ET SK hynix Inc. (SKHY) Stock 4 Comments Kenio Fontes Summary - SK hynix delivered stellar Q3 results, beating revenue by 6% and operating income by 8%, with 32% QoQ and 328% YoY revenue growth. - EBITDA margin reached an all-time high of 84%, driven by supply constraints and robust pricing, while LTAs now cover half of 2027/2028 capacity, boosting visibility. - Management expects mid-20% DRAM and high-teens NAND growth through 2027, with HBM and DRAM volumes potentially sold out through 2029 v
Needham raised its target to $235 from $220 and cited a P/E of 5.6.
Retrieved source passage
Needham raises SK Hynix stock price target to $235 on supply outlook By Investing.com Needham raises SK Hynix stock price target to $235 on supply outlook Analyst Ratings Published Oct 28, 2026, 07:14 AM In this article: SKHY+13.30% Investing.com - Needham raised its price target on SK Hynix Inc. (NASDAQ:SKHY) to $235 from $220 while maintaining a Buy rating on the stock. The firm cited the company’s third-quarter results, which exceeded expectations for both DRAM and NAND products. The memory chip maker’s financial strength is evident in its impressive 76% gross profit margin and remarkably low P/E ratio of 5.6, suggesting strong profitability despite recent market volatility. Needham sai
Supply sold out through 2029 and 14 LTA customers support the toll-booth framing.
Retrieved source passage
SKHY Stock Jumps Premarket: Strategist Says SK Hynix Sits At AI’s ‘Toll Booth’ As Tech Giants Chase Scarce Memory SKHY Stock Jumps Premarket: Strategist Says SK Hynix Sits At AI’s ‘Toll Booth’ As Tech Giants Chase Scarce Memory Deepti Sri Wed, October 28, 2026 at 4:24 AM EDT 4 min read Innes said scarce HBM is helping SK Hynix collect profits, while tech giants face pressure to justify AI spending. Long-term agreements with 14 major customers cover more than half of production capacity for 2027 and 2028. SK Hynix said DRAM and HBM supply is sold out until 2029, with memory shortages expected through 2030. U.S.-listed shares of SK Hynix (SKHY) jumped 8% in premarket trading on Wednesd
SKHY closes above the $235 Needham target within 30 trading days; we regard this as a low-probability (<10%) outcome.
$235 is Needham's Buy-rated target, about +45% from spot.
Retrieved source passage
Needham raises SK Hynix stock price target to $235 on supply outlook By Investing.com Needham raises SK Hynix stock price target to $235 on supply outlook Analyst Ratings Published Oct 28, 2026, 07:14 AM In this article: SKHY+13.30% Investing.com - Needham raised its price target on SK Hynix Inc. (NASDAQ:SKHY) to $235 from $220 while maintaining a Buy rating on the stock. The firm cited the company’s third-quarter results, which exceeded expectations for both DRAM and NAND products. The memory chip maker’s financial strength is evident in its impressive 76% gross profit margin and remarkably low P/E ratio of 5.6, suggesting strong profitability despite recent market volatility. Needham sai
Cantor cut its target from $300 to $250 on CXMT and AI-spending worries, showing Street targets are being revised down as well as up.
Retrieved source passage
Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far TIKR.com Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far Gian Estrada • 5 minute read Reviewed by: David Hanson Last updated Oct 27, 2026 cyano66 from Getty Images and Petrovich9 from Getty Images Signature via Canva Key Takeaways - Cantor Fitzgerald cut its SK hynix price target to $250 from $300 on Oct. 26 and kept its Overweight rating. The new target is 75% above Monday’s close. - SK hynix is 28% below its September high after China’s CXMT claimed a denser DRAM design and worries about AI spending came back. - The $250 target works out to about 7.4x next-twelve-months earnings, against about
SKHY revisits and closes below $145 within 30 trading days, meaning the Oct 28 gap fully fades; we regard this as a roughly 35% outcome.
The CXMT denser-DRAM claim and renewed AI-capex worries drove a 28% drawdown and could re-emerge.
Retrieved source passage
Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far TIKR.com Cantor Fitzgerald’s $250 Target Says SK hynix’s Selloff Went Too Far Gian Estrada • 5 minute read Reviewed by: David Hanson Last updated Oct 27, 2026 cyano66 from Getty Images and Petrovich9 from Getty Images Signature via Canva Key Takeaways - Cantor Fitzgerald cut its SK hynix price target to $250 from $300 on Oct. 26 and kept its Overweight rating. The new target is 75% above Monday’s close. - SK hynix is 28% below its September high after China’s CXMT claimed a denser DRAM design and worries about AI spending came back. - The $250 target works out to about 7.4x next-twelve-months earnings, against about
Fundamental momentum and long-term contract visibility argue against a full fade.
Retrieved source passage
SK hynix Q3: The Memory Cycle May Have Changed. Has The Market Noticed? (NASDAQ:SKHY) Seeking Alpha SK hynix Q3: The Memory Cycle May Have Changed. Has The Market Noticed? Oct 28, 2026, 8:15 AM ET SK hynix Inc. (SKHY) Stock 4 Comments Kenio Fontes Summary - SK hynix delivered stellar Q3 results, beating revenue by 6% and operating income by 8%, with 32% QoQ and 328% YoY revenue growth. - EBITDA margin reached an all-time high of 84%, driven by supply constraints and robust pricing, while LTAs now cover half of 2027/2028 capacity, boosting visibility. - Management expects mid-20% DRAM and high-teens NAND growth through 2027, with HBM and DRAM volumes potentially sold out through 2029 v
What changed
Complete, timestamped thesis history.
-
Invalidation rule triggeredThe SKHY post-earnings thesis has been closed following a breach of the $135 invalidation level. The initial "WATCH" status is no longer applicable given that the price action has invalidated the established thesis parameters. · $163.19
-
Thesis publishedWATCH · LOW conviction
Setup
SKHY is at $162.16. Two facts must be reconciled. Fundamentals just printed a record, and the tape has been brutal. The stock is -14.3% over 5 days and -20.15% over 20 days. Cantor's note puts it 28% below its September high after CXMT's denser-DRAM claim and renewed AI-capex worries (TIKR). Needham's note shows a +13.3% day on the Q3 print (Investing.com).
Cantor's "75% above Monday's close" for a $250 target implies an Oct 26 close near $143. That makes today's price about +13.5% above the reset low, which squares with the Oct 28 jump. It also means the RSI of 31.2 and the momentum readings likely do not fully reflect that gap, so they are probably stale. The platform data does not say, and we flag that uncertainty.
Verdict: WATCH, low conviction. The engine is Neutral (53/100, 39% calibrated win probability). The short cohort is verified at only 47.8% over 757 signals, below a coin flip. The long cohort is unknown. No T+30 cohort covers this name.
Evidence & Data
| Metric | Value | Source |
|---|---|---|
| Q3 revenue growth | +32% QoQ, +328% YoY | G1 |
| Beat vs. expectations | Revenue +6%, operating income +8% | G1 |
| EBITDA margin | 84% (record) | G1 |
| Gross margin / P/E | 76% / 5.6x | G2 |
| Cantor NTM P/E at target | ~7.4x | G3 |
| LTA coverage | 14 customers, over half of 2027/28 capacity | G4 |
Analyst consensus. The sources we have are uniformly constructive. Needham rates it Buy with a $235 target (+44.9%), and Cantor rates it Overweight with a $250 target (+54.2%). I could not retrieve a full consensus tally, so this is a sample of two rather than the majority view.
Technicals. The stack is conflicted. RSI of 31.2, MACD of -5.544 and the -20% 20-day momentum point to oversold downtrend conditions. The SMA trend still reads bullish, and the composite is Underweight at -0.244.
News sentiment. Post-print news flow is positive. It includes supply sold out through 2029 and shortages expected through 2030 (Yahoo Finance). The offset is the CXMT competitive claim and AI-spending scepticism.
Macro. The retrieved sources contain no rates, cycle or rotation data, and I will not invent any. What the evidence does show is that the sector tape is driven by AI-capex sentiment. A 28% drawdown followed by a 13% bounce is a high-beta, crowded expression of that theme.
Consensus vs. variant. The consensus view is that a 5.6x-7.4x P/E on record margins is a gift and that the selloff went too far. We agree that LTA coverage of half of 2027/28 capacity is real visibility, and a single-digit multiple does price in a margin peak. Where we differ is on timing. A stock that moved 28% down and then 13% up in days has not shown that sellers are exhausted. The platform's own record shows directional calls against Neutral engine reads were right only 36.8% of the time. We therefore take a bullish view of the fundamentals and no view on the next 30 days of price.
Scenario Analysis
| Scenario | Probability | Price path | Thesis impact |
|---|---|---|---|
| Re-rate on LTA visibility | 25% | $210 (+29%) | Confirms the fundamental view; the $190 trigger is hit |
| Range-bound digestion | 40% | $165 (+2%) | No edge; WATCH is correct |
| Retest of reset low | 25% | $135 (-17%) | Invalidation level tested |
| CXMT/AI-capex break | 10% | $110 (-32%) | Fundamental narrative challenged |
EV = 0.25×$210 + 0.40×$165 + 0.25×$135 + 0.10×$110 = $163.25, +0.7% vs current.
An EV that close to spot is why we do not publish a direction. It sits well short of the platform's +5% per-call bar.
Catalysts & Risks
- Upside catalysts: further LTA disclosures, Street target raises following Needham's, and evidence that AI-capex guidance holds.
- Downside risks: CXMT's denser-DRAM claim gaining credibility, and AI-spending worries returning (both G3).
- Evidence gaps: the sources are heavily sell-side and bullish, there is no options flow signal, and the macro backdrop could not be sourced.
- Cycle risk: 84% EBITDA margins and +328% YoY growth are peak-like readings. The mid-20% DRAM growth guidance through 2027 is management's claim (G1).
What Changes Our Mind
| Trigger | Level | Action |
|---|---|---|
| Close above | $190 (within 30 trading days) | Upgrade toward BULLISH, as price would reclaim the pre-drawdown level |
| Close below | $135 | Invalidates the post-earnings-reset thesis; reassess toward BEARISH |
| Close below | $145 | Gap-fade warning; the odds of a full retest rise |
| Engine composite | above 60/100 with a verified long cohort | Allows a directional call to publish |
We set the invalidation at $135, below the ~$143 reset low rather than at it. The engine's lesson that 5 of the last 5 theses were invalidated on their own claims argues for levels wider than obvious support.
This is educational market commentary, not investment advice.
More from QL Research
- FPS · WATCH — FPS: Engine Strong Sell, Calibrated Coin-Flip — WATCH $25.75/$29.16
- PUBLIC-COM · WATCH — PUBLIC-COM (Private): Five Events in 48 Hours, No Tape, No Terms — WATCH (LOW)
- RAMP · WATCH — RAMP at $38.24: A Coin Flip Priced on Both Sides — WATCH With $43/$34 Triggers
- RAMP · WATCH — RAMP at $38.24: The Sell Target and the Engine Are Both Loading — Neither Side Is Priced With Edge
- SARONIC · WATCH — Saronic (Private): Fleet-Scale Ambition at a ~$4B Reported Mark — WATCH Until the Navy Writes a Production Check
- SRRK · WATCH — SRRK: Bearish Tape, Unverified Edge — WATCH With $37/$46 Triggers